Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review

被引:10
作者
Rabiei, Morteza [1 ]
Kashanian, Soheila [1 ,2 ,3 ,4 ]
Samavati, Seyedeh S. [1 ]
Jamasb, Shahriar [5 ]
McInnes, Steven J. P. [6 ]
机构
[1] Razi Univ, Dept Nanobiotechnol, Kermanshah, Iran
[2] Razi Univ, Fac Chem, Sensor & Biosensor Res Ctr SBRC, Kermanshah, Iran
[3] Razi Univ, Nanosci & Nanotechnol Res Ctr NNRC, Kermanshah, Iran
[4] Kermanshah Univ Med Sci, Nano Drug Delivery Res Ctr, Kermanshah, Iran
[5] Hamedan Univ Technol, Dept Biomed Engn, Hamadan 6516913733, Hamadan, Iran
[6] Univ South Australia, Div Informat Technol Engn & Environm, Mawson Lakes, SA 5095, Australia
关键词
Neurological diseases; blood-brain barrier; nanotechnology; nanoparticles; targeted delivery; hydrophobicity; DRUG-DELIVERY; INTRANASAL DELIVERY; POLYMERIC NANOPARTICLES; PHOTOTHERMAL THERAPY; IN-VITRO; BARRIER; STRATEGIES; MANAGEMENT; SYSTEM; NEUROPROTECTION;
D O I
10.2174/1389201020666191203094057
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Treatment of neurological diseases using systemic and non-surgical techniques presents a significant challenge in medicine. This challenge is chiefly associated with the condensation and coherence of the brain tissue. Methods: The coherence structure of the brain is due to the presence of the blood-brain barrier (BBB). which consists of a continuous layer of capillary endothelial cells. The BBB prevents most drugs from entering the brain tissue and is highly selective, permitting only metabolic substances and nutrients to pass through. Results: Although this challenge has caused difficulties for the treattnent of neurological diseases. it has opened up a broad research area in the field of drug delivery. Through the utilization of nanoparticles (NI's). nanotechnology can provide the ideal condition for passing through the BBB. Conclusion: NPs with suitable dimensions and optimum hydrophobicity and charge. as well as appropriate functionalization, can accumulate in the brain. Furthermore, NPs can facilitate the targeted delivery of therapeutics into the brain areas involved in Alzheimer's disease, Parkinson's disease, stroke, glioma, migraine, and other neurological disorders. This review describes these methods of actively targeting specific areas of the brain.
引用
收藏
页码:374 / 383
页数:10
相关论文
共 62 条
  • [1] Formulation and evaluation of nano lipid formulation containing CNS acting drug: molecular docking, in-vitro assessment and bioactivity detail in rats
    Alam, Mahtab
    Najmi, Abul Kalam
    Ahmad, Iqbal
    Ahmad, Farhan Jalees
    Akhtar, Md Jawaid
    Imam, Syed Sarim
    Akhtar, Mohd
    [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 : 46 - 57
  • [2] From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery
    Banks, William A.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (04) : 275 - +
  • [3] Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro
    Baysal, Ipek
    Ucar, Gulberk
    Gultekinoglu, Merve
    Ulubayram, Kezban
    Yabanoglu-Ciftci, Samiye
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2017, 124 (01) : 33 - 45
  • [4] Breaching the Blood-Brain Barrier for Drug Delivery
    Bell, Robert D.
    Ehlers, Michael D.
    [J]. NEURON, 2014, 81 (01) : 1 - 3
  • [5] Development of surface-engineered PLGA nanoparticulate-delivery system of Tet 1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer's disease
    Bhatt, Prakash Chandra
    Verma, Amita
    Al-Abbasi, Fahad A.
    Anwar, Firoz
    Kumar, Vikas
    Panda, Bibhu Prasad
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 : 8749 - 8768
  • [6] Blanco-Prieto M. J., 2015, BRAIN AGING PARKINSO
  • [7] Calcium Carbonate-Based Mucoadhesive Microcontainers for Intranasal Delivery of Drugs Bypassing the Blood–Brain Barrier
    Borodina T.N.
    Trushina D.B.
    Marchenko I.V.
    Bukreeva T.V.
    [J]. Trushina, D.B. (trushina.d@mail.ru), 2016, Springer Science and Business Media, LLC (06) : 261 - 268
  • [8] Modern methods for delivery of drugs across the blood-brain barrier
    Chen, Yan
    Liu, Lihong
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (07) : 640 - 665
  • [9] Improving drug delivery technology for treating neurodegenerative diseases
    Choonara, Yahya E.
    Kumar, Pradeep
    Modi, Girish
    Pillay, Viness
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (07) : 1029 - 1043
  • [10] Liposomes and lipid disks traverse the BBB and BBTB as intact forms as revealed by two-step Forster resonance energy transfer imaging
    Dai, Tongcheng
    Jiang, Kuan
    Lu, Weiyue
    [J]. ACTA PHARMACEUTICA SINICA B, 2018, 8 (02) : 261 - 271